Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma

por Ramp, U, Dejosez, M, Mahotka, C, Czarnotta, B, Kalinski, T, Wenzel, M, Lorenz, I, Müller, M, Krammer, P, Gabbert, H E, Gerharz, C D
Publicado 2000